Rigel Pharmaceuticals | 营业费用





营业费用 更改 日
Agenus USD -274.14M 80.46M 2025-09
Amgen USD 5.9B 773M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 223.22M 10.86M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Celldex Therapeutics USD 598.36M 533.78M 2025-09
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Heron Therapeutics USD 38.47M 4M 2024-09
Intrexon USD 61.56M 26.1M 2024-06
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
MacroGenics USD 67M 8M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
Veracyte USD 108.76M 7.09M 2025-09


Rigel Pharmaceuticals 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.